Cardiac operations in patients 90 years of age and older

Ann Thorac Surg. 1997 Jun;63(6):1685-90. doi: 10.1016/s0003-4975(97)00091-x.

Abstract

Background: Growth of the elderly population worldwide, and specifically in the United States, will continue to accelerate and will have a profound impact on the cost and delivery of health care resources in the future. A medical strategy that allows the elderly to live independently is essential to most cost-effective use of our resources. The question remains as to what will be the future of surgical therapy for this increasing population.

Methods: We retrospectively studied the cases of 30 consecutive nonagenarians (mean age, 92.3 +/- 1.8 years) who underwent a cardiac operation within a 9-year period. All patients were in New York Heart Association class III or IV and underwent operation urgently or emergently.

Results: The 30-day mortality rate was 10%, and the actuarial survival rates were 81% +/- 8% and 75% +/- 9% at 1 year and 2 years, respectively. Seventy-eight percent of survivors were in New York Heart Association class I or II within 2 years after operation and had an improved quality of life. The cost of providing care in this age group was 24% higher than in octogenarians.

Conclusions: Advanced age in and of itself (>90 years) should not be a contraindication to an open-heart operation, although morbidity, mortality, and cost may be higher. However, selective criteria identifying risks and benefits for individual patients should be applied. The aging of our population will have a profound impact on the cost and delivery of health care resources in the future. This issue must be addressed in the current debate on the provision of expensive procedures under a realigned national health-care system.

MeSH terms

  • Actuarial Analysis
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Cardiopulmonary Bypass / economics*
  • Cardiopulmonary Bypass / mortality*
  • Cost-Benefit Analysis
  • Female
  • Follow-Up Studies
  • Health Care Costs
  • Humans
  • Length of Stay / economics
  • Male
  • Patient Satisfaction
  • Quality of Life*
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome